The association between tumor mutational burden and prognosis is dependent on treatment context
Sign Up to like & getrecommendations! Published in 2021 at "Nature genetics"
DOI: 10.1038/s41588-020-00752-4
Abstract: In multiple cancer types, high tumor mutational burden (TMB) is associated with longer survival after treatment with immune checkpoint inhibitors (ICIs). The association of TMB with survival outside of the immunotherapy context is poorly understood.… read more here.
Keywords: tumor mutational; treatment; tmb associated; mutational burden ... See more keywords